Infection Prevention
Each year, hospital aquired infections (HAIs) cause hospitals to lose billions of dollars and countless lives. At the root of many of these HAIs are waterborne pathogens which can lead to the development of complications such as Urinary Tract Infections, Legionnaire's Disease and Nosocomial Pneumonia. In fact, the leading cause of death from HAIs is Nosocomial Pneumonia, which is also the 6th overall leading cause of death in the United States.
"Each year, there are nearly 3 million cases of Hospital Acquired Nosocomial Pneumonia, resulting in over 150,000 preventable patient deaths"
The development of Nosocomial Pneumonia represents an imbalance between normal host defenses and the ability of microorganisms to colonize and then invade the lower respiratory tract. The primary route through which organisms enter the lower airways is via aspiration of oropharyngeal secretions into the trachea. Without an effective water disinfection system in place, these organisms are free to enter a medical facility through its domestic water supply.
As healthcare trends move towards the standard of pay for performance, it is becoming even more crucial for hospitals to lower their infection rates. Water is often an unsuspected Trojan horse, carrying bacteria into a facility and circumventing many hard fought infection prevention efforts. Every day some of the most prestigious hospitals around the world are using LiquiTech products and services as part of a proactive strategy to improve patient safety.
LiquiTech Environmental is a resource to help hospitals accelerate their quality and safety improvement goals. With a focus on decontaminating patient care areas, hospitals are able to achieve better patient outcomes, enhanced safety, and maintain lower infection rates all while improving financial performance.
Protecting Your Most Vulnerable Patients
Healthcare facilities are populated with highly susceptible individuals whose immune systems are not able to combat infections caused by waterborne pathogens. For immunocompromised patients there is not only a higher risk of infection but also a higher case-fatality rate. These groups include, but certainly are not limited to children, the elderly, individuals undergoing cancer treatments, and ICU patients.
Learn more about how LiquiTech provides solutions and support for your specific industry:
